Child's Nervous System

, Volume 5, Issue 1, pp 38–40 | Cite as

Treatment of glioma with intratumoral instillation of autologous lymphocytes

  • S. N. Bhagwati
Case Reports


Autologous lymphocytes were instilled into the tumor in a girl 15 years of age who had presented with a recurrent left frontoparietal astrocytoma 1.5 years after surgery, radiation, and chemotherapy. She had remissions for 5 weeks, 5 months, and 20 months after the first, second, and third instillations, respectively. The usefulness of intratumoral instillation of autologous lymphocytes [or preferably lymphokine activated killer (LAK) cells with interleukin-2 is demonstrated in such recurrent astrocytomas.

Key words

Immunotherapy Immunotherapy of astrocytoma Intratumoral autologous lymphocyte instillation Treatment of astrocytoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Apuzzo MLJ, Mitchell MS (1981) Immunological aspects of intrinsic glial tumours. J Neurosurg 55:1–18Google Scholar
  2. 2.
    Gately MK, Glaser M, McCarron RM (1982) Mechanisms by which human gliomas may escape cellular immune attack. Acta Neurochir (Wien) 64:175–197Google Scholar
  3. 3.
    Grimm EA, Mazumder A, Zhang HZ, Rosenburg SA (1984) The human lymphokine-activated killer cell phenomenon. In: Pick E (ed) Lymphokines, vol 9. Academic Press, New York, pp 279–311Google Scholar
  4. 4.
    Grimm EA, Ramsey KM, Mazumdar A, Wilson DJ, Djeu JY, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer resistant fresh solid tumour cells by interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841Google Scholar
  5. 5.
    Grimm EA, Ramsey KM, Mazumdar A (1983) Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T. lymphocytes, memory cytoxic thymus derived lymphocytes and natural killer cells. J Exp Med 157:884–897Google Scholar
  6. 6.
    Herberman RB (1974) Cell mediated immunity to tumour cells. Adv Cancer Res 19:207–263Google Scholar
  7. 7.
    Jacob SK, Wilson DJ, Kornblith PL, Grimm EA (1986) In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes. J Neurosurg 64:114–117Google Scholar
  8. 8.
    Jacob SK, Wilson DJ, Kornblith PL, Grimm EA (1986) Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. J Neurosurg 64:743–749Google Scholar
  9. 9.
    Kumar S, Taylor G, Steward JK, Waghe MA, Morris-Jones P (1973) Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system. Int J Cancer 12:194–205Google Scholar
  10. 10.
    Levy NL (1978) Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumours. Immunology 121:903–915Google Scholar
  11. 11.
    Pfreuneschuh M, Shiku H, Takahashi T, Ueda R, Ransohoff J, Oettgen HF, Old LJ (1978) Serological analysis of cell surface antigens of malignant human brain tumour. Proc Natl Acad Sci USA 75:5122–5126Google Scholar
  12. 12.
    Shapiro WR (1982) Treatment of neuroectodermal brain tumours. Ann Neurol 12:231–237Google Scholar
  13. 13.
    Sheikh KMA, Apuzzo MLJ, Weiss MH (1979) Specific cellular immune responses in patients with malignant gliomas. Cancer Res 39:1733–1738Google Scholar
  14. 14.
    Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealy J Jr, Norrel HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333–343Google Scholar
  15. 15.
    Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorfu, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealy J Jr, Owens G, Ransohoff J II, Robertson JT, Shapiro WT, Smith KR Jr, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Engl J Med 303:1323–1329Google Scholar
  16. 16.
    Woosley RE, Mahaley MS Jr, Mahaley JL, Miller GM, Brooks WH (1977) Immunobiology of primary intracranial tumours. 3. Microcytotoxicity assays of specific immune responses of brain tumour patients. J Neurosurg 47:871–885Google Scholar
  17. 17.
    Young H, Kaplan A, Regelson W (1977) Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme. Cancer 40:1037–1044Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • S. N. Bhagwati
    • 1
  1. 1.Medical Research CenterBombay HospitalBombayIndia

Personalised recommendations